Fluconazole Dosing for Candida Albicans Peritonitis
For Candida albicans peritonitis, use fluconazole 800 mg (12 mg/kg) loading dose, then 400 mg (6 mg/kg) daily, as this is an acceptable alternative to echinocandins in non-critically ill patients with fluconazole-susceptible organisms. 1
Initial Treatment Decision Algorithm
The choice between echinocandins and fluconazole depends on clinical severity:
- Critically ill or septic shock patients: Start with an echinocandin (caspofungin 70 mg loading, then 50 mg daily; micafungin 100 mg daily; or anidulafungin 200 mg loading, then 100 mg daily) 1
- Non-critically ill patients with likely fluconazole-susceptible C. albicans: Fluconazole is acceptable as initial therapy 1
The FDA label confirms that for Candida peritonitis, daily doses of 50-200 mg have been used, though optimal dosing is not fully established 2. However, the IDSA guideline provides stronger evidence supporting the higher 400 mg daily maintenance dose for invasive candidiasis 1.
Dosing Regimen Details
Adults:
- Loading dose: 800 mg (12 mg/kg) on day 1
- Maintenance: 400 mg (6 mg/kg) daily 1
- Route: Intravenous or oral (bioavailability is excellent) 1
Pediatric Patients (≥3 months):
- Loading dose: 25 mg/kg on day 1 (not to exceed 800 mg)
- Maintenance: 12 mg/kg daily (not to exceed 400 mg) 2
Neonates:
- Gestational age ≥30 weeks: 25 mg/kg loading, then 12 mg/kg daily
- Gestational age <30 weeks: 25 mg/kg loading, then 9 mg/kg daily 2
Critical Management Points
Always obtain susceptibility testing on all Candida isolates from peritonitis 1. While C. albicans is typically fluconazole-susceptible, resistance can occur and would necessitate treatment modification.
Source control is essential: Surgical management of the underlying peritonitis (drainage, repair of perforation) must accompany antifungal therapy 3. Research shows that fluconazole achieves excellent peritoneal penetration, with concentrations well above MIC for most Candida species 4, 5.
Duration of Therapy
Continue treatment for at least 2 weeks following resolution of symptoms and clearance of infection 1. For peritoneal dialysis-associated peritonitis, some experts recommend up to 6 weeks of therapy 6.
When to Switch from Echinocandin
If you started with an echinocandin due to critical illness, transition to fluconazole within 5-7 days once the patient is clinically stable, cultures confirm fluconazole-susceptible C. albicans, and repeat cultures are negative 1.
Renal Dosing Adjustments
For creatinine clearance ≤50 mL/min (without dialysis): Give the full loading dose, then reduce maintenance dose by 50% 2. For hemodialysis patients: Give 100% of the recommended dose after each dialysis session 2.
Common Pitfalls to Avoid
- Don't underdose: The 400 mg daily maintenance dose (not 200 mg) is recommended for invasive candidiasis including peritonitis 1
- Don't use fluconazole empirically in critically ill patients: Start with an echinocandin until susceptibilities are known 1
- Don't assume all Candida is susceptible: C. glabrata shows reduced susceptibility (20-28% resistance in ICU studies) 7, and C. krusei is inherently resistant 1
- Don't stop too early: Premature discontinuation leads to relapse 1
The evidence strongly supports this dosing regimen, with the 2016 IDSA guidelines providing the most authoritative recommendations based on high-quality evidence for candidemia and invasive candidiasis 1. Research confirms excellent peritoneal penetration and clinical efficacy when combined with appropriate surgical management 8, 7.